@Vision_DMD Profile picture

Vision-DMD Project

@Vision_DMD

Project aiming to advance clinical development of orphan drug Vamorolone for treatment of DMD.

Joined October 2016
Similar User
World Duchenne Organization photo

@worldduchenne

Parent Project Muscular Dystrophy (PPMD) photo

@ParentProjectMD

Action Duchenne photo

@ActionDuchenne

TREAT-NMD photo

@TREAT_NMD

CureDuchenne photo

@CureDuchenne

Jett Foundation photo

@JettFoundation

Pathfinders Neuromuscular Alliance photo

@PathfindersNMA

Coalition Duchenne photo

@CoalitionDMD

JWMDRC photo

@jwmdrc

World Muscle Society photo

@WorldMuscleSoc

ENMC photo

@_ENMC

AnnemiekeAartsma-Rus photo

@oligogirl

Solid Biosciences photo

@Solid_Bio

Duchenne UK photo

@DuchenneUK

Parent Project aps photo

@Parent_Project

The VISION-DMD project is proud to announce ' Santhera have Received Positive CHMP Opinion Recommending Approval of AGAMREE® (vamorolone) for the Treatment of Duchenne Muscular Dystrophy' Read the press release here CHMP-press-release.pdf (vision-dmd.info)


VISION-DMD rare disease day final project newsletter - mailchi.mp/d0b9b678c1c7/v…


Vision-DMD Project Reposted

Eric Hoffman, Suzanne Gaglianone @smgag19 from @ReveraGen and Ritchie Head from Ceratium share their experience on what Patient Organizations can do to have data return from clinical trials #DPA2021 #duchenne

Tweet Image 1

Vision-DMD Project Reposted

''Patients want their data returned after a clinical trial'' Ritchie Head from Ceratium, is talking about the patients preferences on the return of their data following a clinical trial. #DPA2021 #duchenne

Tweet Image 1

Vision-DMD Project Reposted

Throughout the study, Vamorolone: → Showed sustained efficacy across multiple endpoints over 48 weeks → Good safety and tolerability profile was confirmed More about the topline results from the @Vision_DMD study 👇 worldduchenne.org/news/topline-r…


Latest news and events from VISION-DMD - mailchi.mp/3e7edb9c269e/l…


Come and visit us at the WODC 21- stand 79! #WODC #Raredisease #DMD @jwmdrc @worldduchenne

Tweet Image 1

Vision-DMD Project Reposted

💬 What is the patient perspective on returning individual clinical trial data back to participants after a trial has ended? Help @Vision_DMD answer this question. Please complete this short 4-minute survey 👇 worldduchenne.org/news/return-of… #Duchenne #ClinicalTrial #HealthData


Vision-DMD Project Reposted

🚨 Important notice on 'stem cell therapy for Duchenne'. Please RT! → Currently, there are no approved stem cell therapies for #Duchenne → You NEVER pay for a clinical trial → If a ‘trial’ is not on clinicaltrials.gov, it is not a legitimate trial worldduchenne.org/news/warning-o…


The power of collaboration: Positive results in VISION DMD study funded by #Horizon2020, #DMD #PatientGroups and US Gov – we are now entering the final phase towards Market Authorisation @santhera @ReveraGen @CORDIS_EU @EUScienceInnov #WDAD2021

Tweet Image 1

Today, @Santhera and @ReveraGen announce topline results with Vamorolone in pivotal VISION-DMD study. Santhera will hold a conference call / webcast today at 16:00 CEST, 15:00 BST, 10:00 EDT. Details: globenewswire.com/news-release/2…


Latest news from the VISION-DMD project - mailchi.mp/8a61e124358e/l…

Tweet Image 1

Vision-DMD Project Reposted

Thanks #EUfunded @EJPRareDiseases research co-fund for advertising this White Paper of #EUfunded research @Vision_DMD project: returning individual clinical trial results back to patients - important not only for rare disease patients ! @EU_H2020 #ResearchImpactEU

New VISION-DMD White Paper: Returning Individual Clinical Trial Results Back To Patients. It focuses on addressing the ethical and technical challenges, using the vamorolone clinical trial experience. #clinicaltrials #scicomm #medtech vision-dmd.info/return-of-pati…



Vision-DMD Project Reposted

Impressive achievement: a case study to enable returning own trial results back to single patients.

📍 New VISION-DMD White Paper: Returning Individual Clinical Trial Results Back To Patients. It focuses on addressing the ethical and technical challenges, using the vamorolone clinical trial experience. #clinicaltrials #scicomm #medtech vision-dmd.info/return-of-pati…

Tweet Image 1


📍 New VISION-DMD White Paper: Returning Individual Clinical Trial Results Back To Patients. It focuses on addressing the ethical and technical challenges, using the vamorolone clinical trial experience. #clinicaltrials #scicomm #medtech vision-dmd.info/return-of-pati…

Tweet Image 1

Interesting talks, free and online


Loading...

Something went wrong.


Something went wrong.